| Product Code: ETC6362589 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium continues to see significant import shipments of pyruvate kinase, with top exporters including Denmark, Netherlands, Germany, China, and the USA. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stands at a healthy 6.53%, with a notable growth spike of 15.63% from 2023 to 2024. This data suggests a strong and growing demand for pyruvate kinase in Belgium, driven by imports from key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Pyruvate Kinase Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Pyruvate Kinase Market - Industry Life Cycle |
3.4 Belgium Pyruvate Kinase Market - Porter's Five Forces |
3.5 Belgium Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Belgium Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Belgium |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Technological advancements in diagnostics and treatment options for pyruvate kinase deficiency |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for pyruvate kinase disorders |
4.3.2 High cost associated with advanced diagnostics and treatment for pyruvate kinase deficiency |
5 Belgium Pyruvate Kinase Market Trends |
6 Belgium Pyruvate Kinase Market, By Types |
6.1 Belgium Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Belgium Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Belgium Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Belgium Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Belgium Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Belgium Pyruvate Kinase Market Export to Major Countries |
7.2 Belgium Pyruvate Kinase Market Imports from Major Countries |
8 Belgium Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of new cases diagnosed with pyruvate kinase deficiency annually in Belgium |
8.2 Adoption rate of advanced diagnostic technologies for pyruvate kinase disorders in Belgium |
8.3 Patient satisfaction levels with the quality of care and treatment options for pyruvate kinase deficiency in Belgium |
9 Belgium Pyruvate Kinase Market - Opportunity Assessment |
9.1 Belgium Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Belgium Pyruvate Kinase Market - Competitive Landscape |
10.1 Belgium Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Belgium Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |